These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16882883)

  • 1. Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure.
    Schiekofer S; Shiojima I; Sato K; Galasso G; Oshima Y; Walsh K
    Physiol Genomics; 2006 Oct; 27(2):156-70. PubMed ID: 16882883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversibility of adverse, calcineurin-dependent cardiac remodeling.
    Berry JM; Le V; Rotter D; Battiprolu PK; Grinsfelder B; Tannous P; Burchfield JS; Czubryt M; Backs J; Olson EN; Rothermel BA; Hill JA
    Circ Res; 2011 Aug; 109(4):407-17. PubMed ID: 21700928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term akt activation in cardiac muscle cells improves contractile function in failing hearts.
    Shiojima I; Schiekofer S; Schneider JG; Belisle K; Sato K; Andrassy M; Galasso G; Walsh K
    Am J Pathol; 2012 Dec; 181(6):1969-76. PubMed ID: 23031259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failure.
    Das B; Young D; Vasanji A; Gupta S; Sarkar S; Sen S
    Cardiovasc Res; 2010 Aug; 87(3):524-34. PubMed ID: 20202977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.
    Shiojima I; Sato K; Izumiya Y; Schiekofer S; Ito M; Liao R; Colucci WS; Walsh K
    J Clin Invest; 2005 Aug; 115(8):2108-18. PubMed ID: 16075055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous deletion of AKT1 rescues cardiac contractility, but not hypertrophy, in a mouse model of Noonan Syndrome with Multiple Lentigines.
    Roy R; Krenz M
    J Mol Cell Cardiol; 2017 Nov; 112():83-90. PubMed ID: 28911943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological growth synergizes with pathological genes in experimental cardiomyopathy.
    Syed F; Odley A; Hahn HS; Brunskill EW; Lynch RA; Marreez Y; Sanbe A; Robbins J; Dorn GW
    Circ Res; 2004 Dec; 95(12):1200-6. PubMed ID: 15539635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac hypertrophy and dysfunction induced by overexpression of miR-214 in vivo.
    Yang T; Gu H; Chen X; Fu S; Wang C; Xu H; Feng Q; Ni Y
    J Surg Res; 2014 Dec; 192(2):317-25. PubMed ID: 25085702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional effects of chronic Akt activation in the heart.
    Cook SA; Matsui T; Li L; Rosenzweig A
    J Biol Chem; 2002 Jun; 277(25):22528-33. PubMed ID: 11956204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic-regulatory network revealed by molecular profiling heart tissue following Akt1 induction in endothelial cells.
    Schiekofer S; Belisle K; Galasso G; Schneider JG; Boehm BO; Burster T; Schmitz G; Walsh K
    Angiogenesis; 2008; 11(3):289-99. PubMed ID: 18491207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial reverse remodeling after pressure unloading is associated with maintained cardiac mechanoenergetics in a rat model of left ventricular hypertrophy.
    Ruppert M; Korkmaz-Icöz S; Li S; Németh BT; Hegedűs P; Brlecic P; Mátyás C; Zorn M; Merkely B; Karck M; Radovits T; Szabó G
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H592-603. PubMed ID: 27342874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy.
    Molojavyi A; Lindecke A; Raupach A; Moellendorf S; Köhrer K; Gödecke A
    Physiol Genomics; 2010 Apr; 41(2):137-45. PubMed ID: 20145201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure.
    Galindo CL; Skinner MA; Errami M; Olson LD; Watson DA; Li J; McCormick JF; McIver LJ; Kumar NM; Pham TQ; Garner HR
    BMC Physiol; 2009 Dec; 9():23. PubMed ID: 20003209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connexin43 and zonula occludens-1 are targets of Akt in cardiomyocytes that correlate with cardiac contractile dysfunction in Akt deficient hearts.
    Ock S; Lee WS; Kim HM; Park KS; Kim YK; Kook H; Park WJ; Lee TJ; Abel ED; Kim J
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1183-1191. PubMed ID: 29378301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure.
    Buermans HP; Redout EM; Schiel AE; Musters RJ; Zuidwijk M; Eijk PP; van Hardeveld C; Kasanmoentalib S; Visser FC; Ylstra B; Simonides WS
    Physiol Genomics; 2005 May; 21(3):314-23. PubMed ID: 15728335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
    Major JL; Salih M; Tuana BS
    J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac-specific PID1 overexpression enhances pressure overload-induced cardiac hypertrophy in mice.
    Liu Y; Shen Y; Zhu J; Liu M; Li X; Chen Y; Kong X; Song G; Qian L
    Cell Physiol Biochem; 2015; 35(5):1975-85. PubMed ID: 25871431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice.
    Engelhardt S; Hein L; Keller U; Klämbt K; Lohse MJ
    Circ Res; 2002 Apr; 90(7):814-9. PubMed ID: 11964375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac overexpression of myotrophin triggers myocardial hypertrophy and heart failure in transgenic mice.
    Sarkar S; Leaman DW; Gupta S; Sil P; Young D; Morehead A; Mukherjee D; Ratliff N; Sun Y; Rayborn M; Hollyfield J; Sen S
    J Biol Chem; 2004 May; 279(19):20422-34. PubMed ID: 14970239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted expression of a dominant-negative K(v)4.2 K(+) channel subunit in the mouse heart.
    Wickenden AD; Lee P; Sah R; Huang Q; Fishman GI; Backx PH
    Circ Res; 1999 Nov; 85(11):1067-76. PubMed ID: 10571538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.